Learn the exact dose escalation schedules for Wegovy and Zepbound, why slow titration reduces GI side effects, and when and how to delay or adjust dose increases.
標籤彙整: tirzepatide
The Science Behind the Weight Loss Numbers: STEP and SURMOUNT Trial Results Explained
A plain-language breakdown of the STEP (semaglutide) and SURMOUNT (tirzepatide) Phase 3 clinical trials: design, results, limitations, and what the weight loss percentages really mean for patients.
What Are GLP-1 Receptor Agonists? Understanding the Gut Hormone That Changed Weight Loss Medicine
Learn what GLP-1 receptor agonists are, how the incretin hormone GLP-1 regulates appetite and blood sugar, and why these medications have transformed obesity medicine.
Mounjaro & Zepbound (Tirzepatide) Complete Guide: The Dual GIP/GLP-1 Agonist Explained
Explore tirzepatide’s unique dual GIP and GLP-1 receptor agonism, the SURMOUNT-1 trial’s 22.5% weight loss results, dosing schedule, and differences between Mounjaro and Zepbound.
Wegovy vs. Mounjaro: A Clinical Comparison of Efficacy, Safety, and Cost
A detailed head-to-head clinical comparison of semaglutide (Wegovy) and tirzepatide (Mounjaro/Zepbound): weight loss outcomes, safety profiles, costs, and how to choose between them.
Managing Nausea on GLP-1 RA Medications: Why It Happens and 10 Evidence-Based Strategies
Nausea affects up to 44% of patients on GLP-1 RA therapy. Learn the neuroscience behind it and 10 evidence-based strategies to reduce discomfort without stopping your medication.
Dealing with Vomiting and Diarrhea on GLP-1 RA: When to Push Through and When to Call Your Doctor
Vomiting and diarrhea affect 20–30% of GLP-1 RA users. Learn which symptoms are expected, which require medical attention, and how to manage hydration and electrolytes safely.
Hitting a Weight Loss Plateau on GLP-1 RA: Why It Happens and Evidence-Based Ways to Break Through
Understand the biology of weight loss plateaus on semaglutide or tirzepatide—metabolic adaptation, muscle loss, behavioral drift—and evidence-based strategies to overcome them.
Drug Interactions with GLP-1 RA Medications: Oral Contraceptives, Thyroid Drugs, and Diabetes Medications
GLP-1 RA medications slow gastric emptying and can alter absorption of oral drugs. Learn about clinically significant interactions with contraceptives, thyroid medications, diabetes drugs, and more.
The Dangers of Compounded Semaglutide and Tirzepatide: FDA Warnings, Quality Risks, and What Patients Must Know
FDA-approved GLP-1 RA medications have safe, verified formulations. Compounded versions carry serious risks including dosing errors, contamination, and unverified ingredients—here’s what you must know.